Expression and characterization of bluetongue virus serotype 21 VP7 antigen: C-terminal truncated protein has significantly reduced antigenicity.

In the present study, group-specific antigen VP7 of bluetongue virus (BTV) serotype 21 isolated from cattle in Tochigi prefecture in Japan in 1994 was characterized by sequencing and expression. Gene was amplified from cDNA synthesized on viral dsRNA using reverse-transcriptase-PCR. Nucleotide sequence of this isolate showed high similarity with other published BTV VP7 sequences. Full-length and C-terminal truncated forms of VP7 were expressed in insect cells by a baculovirus gene expression system under control of the viral polyhedrin promoter. Expression of full-length recombinant VP7 was confirmed by immunoprecipitation with VP7 specific monoclonal antibody (8A3B.6, ATCC). Recombinant proteins expressed with or without 6x His-tag showed good expression levels in TN5 cells and reacted well with the monoclonal antibody in the indirect ELISA. However C-terminal truncated VP7 with His-tag failed to react with this monoclonal antibody, while poor antigenicity was evident when it was reacted with infected bovine serum. Reduced antigenicity of the latter suggested that C-terminal truncation affects 8A3B.6 epitope construction probably via inhibition of VP7 trimer structure formation.

[1]  M. Hosamani,et al.  Prokaryotic expression of truncated VP7 of bluetongue virus (BTV) and reactivity of the purified recombinant protein with all BTV type-specific sera. , 2008, Journal of virological methods.

[2]  M. Sabara,et al.  Production, characterization and assay application of a purified, baculovirus-expressed, serogroup specific bluetongue virus antigen. , 2008, Transboundary and emerging diseases.

[3]  F. Landeg.  Bluetongue outbreak in the UK , 2007, Veterinary Record.

[4]  M. Enserink.  During a Hot Summer, Bluetongue Virus Invades Northern Europe , 2006, Science.

[5]  M. Sabara,et al.  Production of a Recombinant Major Inner Capsid Protein for Serological Detection of Epizootic Hemorrhagic Disease Virus , 2005, Clinical Diagnostic Laboratory Immunology.

[6]  Y. Goto,et al.  Frequency of serological cross-reactions between Ibaraki and bluetongue viruses using the agar gel immunodiffusion test. , 2004, Veterinaria italiana.

[7]  M. Kubo,et al.  Epidemiological observations on bluetongue in sheep and cattle in Japan. , 2004, Veterinaria italiana.

[8]  M. Chan,et al.  Immunoblot Assay as a Confirmatory Test of Competitive ELISA for Serodiagnosis of Bluetongue , 1996, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

[9]  Jonathan Grimes,et al.  The crystal structure of bluetongue virus VP7 , 1995, Nature.

[10]  B. Eaton,et al.  Fine mapping of a surface-accessible, immunodominant site on the bluetongue virus major core protein VP7. , 1994, Virology.

[11]  P. Roy,et al.  A single point mutation in the VP7 major core protein of bluetongue virus prevents the formation of core-like particles , 1993, Journal of virology.

[12]  M. Schartl,et al.  Rapid identification of recombinant baculoviruses using PCR. , 1991, BioTechniques.

[13]  B. Eaton,et al.  High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA. , 1991, Virus research.

[14]  J. White,et al.  A bluetongue serogroup-reactive epitope in the amino terminal half of the major core protein VP7 is accessible on the surface of bluetongue virus particles. , 1991, Virology.

[15]  P. Roy,et al.  Purification and characterization of the major group-specific core antigen VP7 of bluetongue virus synthesized by a recombinant baculovirus. , 1990, The Journal of general virology.

[16]  P. Kitts,et al.  Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors. , 1990, Nucleic acids research.

[17]  J. Appleton,et al.  Monoclonal antibody analysis of serotype-restricted and unrestricted bluetongue viral antigenic determinants. , 1983, Virology.

[18]  G. Viljoen,et al.  Vaccinia virus expression of the VP7 protein of South African bluetongue virus serotype 4 and its use as an antigen in a capture ELISA , 2005, Archives of Virology.

[19]  B. Eaton,et al.  Topography and immunogenicity of bluetongue virus VP7 epitopes , 2005, Archives of Virology.

[20]  H. Akashi,et al.  Seroepizootiological survey on bluetongue virus infection in cattle in Japan. , 1982, National Institute of Animal Health quarterly.